2m 2m 2m 2m 2m 2m 2m
Corvus Pharmacet (CRVS)
NASDAQ
$11.57-$0.12 (-1.03%)
Price as of Jun 03, 2026 7:08 PM EDT- $1.0BMarket Cap
- 183.74%1-Year Change
- BiotechnologyIndustry
Corvus Pharmacet (CRVS)
$11.57-$0.12 (-1.03%)
CRVS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.69 | ||
Change | -$0.39 (-3.23%) | ||
Open | $11.98 | ||
High | $11.98 | ||
Low | $11.44 | ||
Previous Close | $12.08 | ||
Volume | 1,912,807 | ||
30-Day Average Volume | 1,873,484 | ||
1-Week Change | -8.89% | ||
1-Month Change | -24.39% | ||
1-Year Change | 183.74% | ||
3-Year Change | 265.31% | ||
5-Year Change | 331.37% | ||
Fundamentals | |||
Shares Outstanding | 84.1M | ||
Total Assets | $253.2M | ||
Market Cap | $1.0B | ||
Enterprise Value | $1.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$13.7M | ||
Free Cash Flow | -$10.5M | ||
EBIT | -$13.7M | ||
EBITDA | -$13.7M | ||
Net Working Capital | $227.8M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -73 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -83 | ||
PEG | 72 | ||
Price/Free Cash Flow | -100 | ||
Price/Operating Cash Flow | -101 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue